Knockdown of NPM1 by RNA interference inhibits cells proliferation and induces apoptosis in leukemic cell line

International Journal of Medical Sciences

Volumn 8, Issue 4, 2011, Pages 287-294

  Qin, Feng Xian ^a   Shao, Hui Yuan ^a   Chen, Xian Chun ^a   Tan, Shi ^a   Zhang, Hui Juan ^a   Miao, Zong Yu ^a   Wang, Li ^a   Hui Chen, ^a   Zhang, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Leukemic cell; Nucleophosmin; Proliferation; RNA interference

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CASPASE 8; MESSENGER RNA; NUCLEOPHOSMIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL COUNT; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN K 562; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LEUKEMIA; LEUKEMIA CELL LINE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TIME; WESTERN BLOTTING;

EID: 79958849069     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.287     Document Type: Article

References (26)

1. Chan WY, Liu QR, Borjigin J, et al. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry. 1989; 28: 1033-9.
2. Okuwaki, M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem. 2008; 143: 441-8.
3. Sirri V, Roussel P, Gendron MC, et al. Amount of the two major Ag-NOR proteins, nucleolin and protein B23, is cell-cycle de-pendent. Cytometry. 1997; 28: 147-56.
4. Wu MH, Yung BY. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J Biol Chem. 2002; 277: 48234-40.
5. Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 2005; 437: 147-53.
6. Colombo E, Bonetti P, Lazzerini Denchi E, et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol. 2005; 25: 8874-86.
7. Shields LB, Gerçel-Taylor C, Yashar CM, et al. Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig. 1997; 4: 298-304.
8. Nozawa Y, Van Belzen N, Van der Made AC, et al. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol. 1996; 178: 48-52.
9. Tanaka M, Sasaki H, Kino I, et al. Genes preferentially ex-pressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res. 1992; 52: 3372-7.
10. Subong EN, Shue MJ, Epstein JI, et al. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate. 1999; 39: 298-304.
11. Pianta A, Puppin C, Franzoni A et al. Nucleophosmin is over-expressed in thyroid tumors. Biochem Biophys Res Commun. 2010; 397: 499-504.
12. Feuerstein N, Chan PK, Mond JJ. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mi-togenesis in Swiss 3T3 fibroblasts and with T lymphocyte pro-liferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol. 1988; 107: 1629-42.
13. Kondo T, Minamino N, Nagamura-Inoue T, et al. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and mani-fests oncogenic activity. Oncogene. 1997; 15: 1275-81.
14. Morris SW, Xue L, Ma Z, et al. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lympho-ma. Br J Haematol. 2001; 113: 275-95.
15. Pandolfi PP. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. Haematologica. 1996; 81: 472-82.
16. Yoneda-Kato N, Look AT, Kirstein MN, et al. The t (3; 5) (q25.1; q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene. 1996; 12: 265-75.
17. Hsu CY, Yung BY. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int J Can-cer. 2000; 88: 392-400.
18. Hsu CY, Yung BY. Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells. Br J Cancer. 2003; 89: 1320-26.
19. Liu WH, Hsu CY, Yung BY. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyr-ate-induced apoptosis and inhibition of telomerase activity. Int J Cancer. 1999; 83: 765-71.
20. Liu, WH, Yung BY. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyr-ate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene. 1998; 17: 3055-64.
21. Bolli N, De Marco MF, Martelli MP, et al. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. Leukemia. 2009; 23: 501-9.
22. Li J, Zhang X, Sejas DP, et al. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leuk Res. 2005; 29: 1415-23.
23. S. Grisendi, C. Mecucci, B. Falini, et al. Nucleophosmin and cancer. Nat Rev Cancer. 2006; 6: 493-505.
24. Herrera JE, Savkur R, Olson MO. The ribonuclease activity of nucleolar protein B23. Nucleic Acids Res. 1995; 23: 3974-79.
25. Jiang PS, Yung BY. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis. Biochem Biophys Res Commun. 1999; 257: 865-70.
26. Bouker KB, Skaar TC, Riggins RB, et al. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis. 2005; 26: 1527-35.